- Release Date: 11/11/20 10:11
- Summary: DSMB Analysis Recommends to Continue P3 COVID-19 ARDS Trial
- Price Sensitive: Yes
- Download Document 117.63KB
Ann: DSMB Analysis Recommends to Continue P3 COVID-19 ARDS Trial
- There are more pages in this discussion • 392 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
0.025(2.26%) |
Mkt cap ! $1.278B | |||
| Open | High | Low | Value | Volume |
| $1.12 | $1.14 | $1.12 | $2.620M | 2.327M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 31810 | $1.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 32115 | 14 |
View Market Depth
| Last trade - 12.25pm 04/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.13 |
Change
0.025 ( 1.37 %) |
||||
| Open | High | Low | Volume | ||
| $1.12 | $1.14 | $1.12 | 620623 | ||
| Last updated 12.44pm 04/06/2024 ? | |||||
| MSB (ASX) Chart |